$24.37
+0.39 (+1.63%)
Open$24.04
Previous Close$23.98
Day High$24.49
Day Low$23.95
52W High$32.63
52W Low$6.44
Volume—
Avg Volume325.3K
Market Cap1.08B
P/E Ratio—
EPS$-1.11
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
+84.5% upside
Current
$24.37
$24.37
Target
$44.96
$44.96
$33.78
$44.96 avg
$58.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 45.88M | 203.59M | 209.55M |
| Net Income | -48,800,925 | 62.98M | 65.23M |
| Profit Margin | -106.4% | 30.9% | 31.1% |
| EBITDA | -66,688,117 | 113.38M | 119.42M |
| Free Cash Flow | — | 53.53M | 45.52M |
| Rev Growth | — | +1.5% | +13.6% |
| Debt/Equity | — | 0.24 | 0.25 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |